Close Menu

This article has been updated to include a statement from Natera.

NEW YORK (GenomeWeb) – CareDx has filed a second lawsuit against Natera today in the United States District Court for Delaware, accusing the company of trying to "mislead" patients and clinicians into thinking that Natera's Prospera kidney transplant test is superior to CareDx's AlloSure organ transplant diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.